Jarrod Mousa, Ph.D.

Jarrod Mousa, Ph.D.

Institution: University of Georgia

Project: Using Monoclonal Antibodies to Protect Against Pneumococcal Pneumonia

Grant(s): Innovation Award

Streptococcus pneumoniae remains a leading cause of bacterial pneumonia and death due to infectious diseases worldwide, despite the use of two effective vaccines. The infection rate remains high due to infection with strains not included in current vaccines. Treatment options can be limited since there has been a rise in antibiotic resistance among non-vaccine strains. We will isolate human monoclonal antibodies to certain pneumococcal surface proteins, and determine their therapeutic efficacy and mechanism of action. Overall, our work will discover new therapies based on highly promising monoclonal antibodies that protect against pneumococcal infection.

Freedom From Smoking Clinic
, | May 02, 2022
Freedom From Smoking Clinic
Virginia Beach, VA | May 10, 2022